サマリー

モンテルカストナトリウムの世界市場 2022-2026 年
Technavioはモンテルカストナトリウム市場を監視しており、2022-2026年の間に18億8000万ドルの成長が見込まれ、予測期間中にCAGR6.1％で加速しています。当レポートでは、モンテルカストナトリウム市場の全体分析、市場規模・予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などをお届けします。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、喘息治療薬に対する需要の増加、患者の意識の向上、強力なパイプラインと新薬の承認によって牽引されています。
モンテルカストナトリウム市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioのモンテルカストナトリウム市場は、以下のようにセグメント化されています。
タイプ別
- 錠剤
- チュアブル錠
- 経口液剤
地域別状況
- 北アメリカ
- 欧州
- APAC
- その他の地域 (ROW)
本研究では、政府や支援団体による患者支援の取り組みが、今後数年間のモンテルカストナトリウム市場の成長を促進する主要な理由の1つであると見なしています。また、共同研究の増加や治癒的アプローチにおける研究の拡大が、市場の大きな需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要なパラメータの分析によって、市場の詳細な図を提示します。モンテルカストナトリウム市場に関する当レポートの対象領域は以下の通りです。
- モンテルカストナトリウムの市場規模
- モンテルカストナトリウムの市場予測
- モンテルカストナトリウム市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Apotex Inc.、Aurobindo Pharma Ltd.、Bio-Techne Corp、Cayman Chemical Co.、Cipla Ltd、Glenmark Pharmaceuticals Ltd、Hetero Healthcare Ltd、Hikma Pharmaceuticals Plc、Jubilant Pharmova Ltd、Krosyl Pharmaceuticals Pvt.Ltd.、Merck and Co., Ltd、Morepen Laboratories Ltdなど複数の主要モンテルカストナトリウム市場ベンダーについての詳細分析を提供しています。Inc.、Morepen Laboratories Ltd.、Novartis AG、Simson Pharma Ltd.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Unichem Laboratories Ltd.、Unimark Remedies Ltd. および Viatris Inc.が含まれています。また、モンテルカストナトリウムの市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後の成長機会をすべて戦略化し、活用できるようにするためです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/montelukast-sodium-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Tablets - Market size and forecast 2021-2026
o Exhibit 28: Chart on Tablets - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Tablets - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Tablets - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Tablets - Year-over-year growth 2021-2026 (%)
o 5.4 Chewable tablets - Market size and forecast 2021-2026
o Exhibit 32: Chart on Chewable tablets - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Chewable tablets - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Chewable tablets - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Chewable tablets - Year-over-year growth 2021-2026 (%)
o 5.5 Oral solutions - Market size and forecast 2021-2026
o Exhibit 36: Chart on Oral solutions - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Oral solutions - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Oral solutions - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Oral solutions - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Type
o Exhibit 40: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 APAC - Market size and forecast 2021-2026
o Exhibit 54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on APAC - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Apotex Inc.
o Exhibit 89: Apotex Inc. - Overview
o Exhibit 90: Apotex Inc. - Product / Service
o Exhibit 91: Apotex Inc. - Key offerings
o 10.4 Aurobindo Pharma Ltd.
o Exhibit 92: Aurobindo Pharma Ltd. - Overview
o Exhibit 93: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 94: Aurobindo Pharma Ltd. - Key offerings
o 10.5 Cipla Ltd.
o Exhibit 95: Cipla Ltd. - Overview
o Exhibit 96: Cipla Ltd. - Business segments
o Exhibit 97: Cipla Ltd. - Key news
o Exhibit 98: Cipla Ltd. - Key offerings
o Exhibit 99: Cipla Ltd. - Segment focus
o 10.6 Glenmark Pharmaceuticals Ltd.
o Exhibit 100: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 101: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 102: Glenmark Pharmaceuticals Ltd. - Key offerings
o 10.7 Jubilant Pharmova Ltd.
o Exhibit 103: Jubilant Pharmova Ltd. - Overview
o Exhibit 104: Jubilant Pharmova Ltd. - Business segments
o Exhibit 105: Jubilant Pharmova Ltd. - Key news
o Exhibit 106: Jubilant Pharmova Ltd. - Key offerings
o Exhibit 107: Jubilant Pharmova Ltd. - Segment focus
o 10.8 Merck and Co. Inc.
o Exhibit 108: Merck and Co. Inc. - Overview
o Exhibit 109: Merck and Co. Inc. - Business segments
o Exhibit 110: Merck and Co. Inc. - Key news
o Exhibit 111: Merck and Co. Inc. - Key offerings
o Exhibit 112: Merck and Co. Inc. - Segment focus
o 10.9 Morepen Laboratories Ltd.
o Exhibit 113: Morepen Laboratories Ltd. - Overview
o Exhibit 114: Morepen Laboratories Ltd. - Key offerings
o 10.10 Sun Pharmaceutical Industries Ltd.
o Exhibit 115: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 116: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 117: Sun Pharmaceutical Industries Ltd. - Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 118: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 119: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 120: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 121: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 122: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 Viatris Inc.
o Exhibit 123: Viatris Inc. - Overview
o Exhibit 124: Viatris Inc. - Business segments
o Exhibit 125: Viatris Inc. - Key offerings
o Exhibit 126: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Tablets - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Tablets - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Tablets - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Tablets - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Chewable tablets - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Chewable tablets - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Chewable tablets - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Chewable tablets - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Oral solutions - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Oral solutions - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Oral solutions - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Oral solutions - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Apotex Inc. - Overview
Exhibits90: Apotex Inc. - Product / Service
Exhibits91: Apotex Inc. - Key offerings
Exhibits92: Aurobindo Pharma Ltd. - Overview
Exhibits93: Aurobindo Pharma Ltd. - Product / Service
Exhibits94: Aurobindo Pharma Ltd. - Key offerings
Exhibits95: Cipla Ltd. - Overview
Exhibits96: Cipla Ltd. - Business segments
Exhibits97: Cipla Ltd. - Key news
Exhibits98: Cipla Ltd. - Key offerings
Exhibits99: Cipla Ltd. - Segment focus
Exhibits100: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits101: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits102: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits103: Jubilant Pharmova Ltd. - Overview
Exhibits104: Jubilant Pharmova Ltd. - Business segments
Exhibits105: Jubilant Pharmova Ltd. - Key news
Exhibits106: Jubilant Pharmova Ltd. - Key offerings
Exhibits107: Jubilant Pharmova Ltd. - Segment focus
Exhibits108: Merck and Co. Inc. - Overview
Exhibits109: Merck and Co. Inc. - Business segments
Exhibits110: Merck and Co. Inc. - Key news
Exhibits111: Merck and Co. Inc. - Key offerings
Exhibits112: Merck and Co. Inc. - Segment focus
Exhibits113: Morepen Laboratories Ltd. - Overview
Exhibits114: Morepen Laboratories Ltd. - Key offerings
Exhibits115: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits116: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits117: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits118: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits119: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits120: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits121: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits122: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits123: Viatris Inc. - Overview
Exhibits124: Viatris Inc. - Business segments
Exhibits125: Viatris Inc. - Key offerings
Exhibits126: Viatris Inc. - Segment focus
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations